Are You Interested In Investing In MannKind Corporation (MNKD)? Check This Out First


As of Friday close, MannKind Corporation’s (NASDAQ:MNKD) stock was down -$0.09, moving down -2.16 percent to $4.07. The average number of shares traded per day over the past five days has been 4,534,920 shares. 1 time new highs have been achieved over the past 5 days, with a -$0.40 fall in that time frame. In the last twenty days, the average volume was 3,883,830, while in the previous 50 days, it was 3,367,944.

Since last month, MNKD stock retreated -24.07%. Shares of the company fell to $3.99 on 03/17/23, the lowest level in the past month. A 52-week high of $5.73 was reached on 02/27/23 after having rallying from a 52-week low of $2.61. Since the beginning of this year, MNKD’s stock price has dropped by -22.77% or -$1.20, and marked a new high 5 times. However, the stock has declined by -28.97% since its 52-week high.

From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio

The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.

Get our free report, "Top 5 AI Stocks to Buy for 2023".


MNKD stock investors should be aware that MannKind Corporation (MNKD) stock had its last reported insider trading activity 17 days ago on Mar 01. Castagna Michael, the Chief Executive Officer of the company, disposed of 10,000 shares for $5.27 on Mar 01. It resulted in a $52,748 divestment by the insider. Thomson David sold 7,000 shares at an average price of $3.67 on Aug 29. The insider now owns 726,035 shares following the transaction. On Aug 22, EVP Endocrine Business Unit Galindo Alejandro sold 4,615 shares at $3.85 apiece. The transaction was valued at $17,771.

Financial Health

In the three months ended September 29, MannKind Corporation’s quick ratio stood at 3.20, while its current ratio was 3.50, showing that the company is able to pay off its debt. On the profitability front, the trailing twelve-month gross margin is 42.40% percent. In the year ended September 29, operating margins totaled -64.20%. Based on annual data, MNKD earned $42.27 million in gross profit and brought in $99.77 million in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was -50.40%. Return on equity (ROE) for the past 12 months was 36.10%.

According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. MNKD’s revenue rose 65.28% to $32.83 million during the quarter, while net income inched up to $36.06 million. While analysts expected MannKind Corporation to report -$0.09 quarterly earnings, the actual figure was -$0.06 per share, beating the consensus estimate by 33.30%. During the quarter, the company generated -$10.84 million in EBITDA. The liabilities of MannKind Corporation were 545.82 million at the end of its most recent quarter ended September 29, and its total debt was $382.69 million. The value of shareholders’ equity is $263.92 million.

Technical Picture

This quick technical analysis looks at MannKind Corporation’s (MNKD) price momentum. With a historical volatility rate of 27.85%, the RSI 9-day stood at 20.45% on 17 March.

With respect to its five-day moving average, the current MannKind Corporation price is down by -8.95% percent or -$0.40. At present, MNKD shares trade -24.21% below its 20-day simple moving average and +22.22% percent above its 100-day simple moving average. However, the stock is currently trading approximately -21.73% below its SMA50 and -2.63% below its SMA200.

Stochastic coefficient K was 6.12% and Stochastic coefficient D was 4.95%, while ATR was 0.25. Given the Stochastic reading of 5.26% for the 14-day period, the RSI (14) reading has been calculated as 27.19%. As of today, the MACD Oscillator reading stands at -0.29, while the 14-day reading stands at -0.48.

Analyst Ratings

RBC Capital Mkts launched its rating on MannKind Corporation (NASDAQ: MNKD) to a Sector perform in a note to investors on May 14, 2021. MannKind Corporation (MNKD) has been rated Buy by analysts. According to 0 brokerage firms, MNKD is a sell, and 1 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 0 analysts rate MannKind Corporation stock as buy, with 5 recommending it as overweight.

With a median target price of $6.75, the current consensus forecast for the stock is $5.00 – $8.00. Based on these forecasts, analysts predict MannKind Corporation (MNKD) will achieve an average price target of $6.67.


Please enter your comment!
Please enter your name here